Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.

ABSTRACT:

Objectives

This study examined the incidence and predictors of antimuscarinic medication use including non-selective antimuscarinics among older adults with dementia and overactive bladder (OAB).

Methods

The study used a new-user cohort design involving older adults (≥65 years) with dementia and OAB based on 2013-2015 Medicare data. Antimuscarinics included non-selective (oxybutynin, tolterodine, trospium, fesoterodine) and selective (solifenacin, darifenacin) medications. Descriptive statistics and multivariable logistic regression models were used to determine the incidence and predictors of new antimuscarinic use including non-selective antimuscarinics, respectively.

Results

Of the 3.38 million Medicare beneficiaries with dementia, over one million (1.05) had OAB (

SUBMITTER: Kachru N 

PROVIDER: S-EPMC9289997 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature